Raymond James lowered the firm’s price target on Crescent Capital BDC (CCAP) to $17 from $20 and keeps an Outperform rating on the shares. While fourth quarter results were well below the firm’s estimates, Raymond James continues to see an attractive risk/reward, with a conservatively implemented variable dividend policy, the analyst tells investors in a research note.
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CCAP:
- Crescent Capital BDC price target lowered to $15 from $16 at Wells Fargo
- Crescent Capital downgraded to Market Perform from Outperform at Keefe Bruyette
- Crescent Capital BDC Reports Q1 2025 Earnings
- Crescent Capital BDC Navigates Earnings Amid Challenges
- Cooperman’s Omega buys Sunoco, exits Arbor and Blue Owl in Q1